MS, PA-C Amy Hacker-Prietz

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Joseph M. Herman · 2 shared papers, 2026 · strength 0.53
   • Paper Nourishing Hope: Five Essential Nutrition Tips for Patients With Pancreatic Cancer. DOI 10.6004/jadpro.2026.17.2.2↗
   • Paper The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced p… DOI 10.1038/s41467-026-69294-3↗
2. Amol Kumar Narang · 2 shared papers, 2026 · strength 0.53
   • Paper Nourishing Hope: Five Essential Nutrition Tips for Patients With Pancreatic Cancer. DOI 10.6004/jadpro.2026.17.2.2↗
   • Paper The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced p… DOI 10.1038/s41467-026-69294-3↗
3. Priya Pathak · 1 shared paper, 2026 · strength 0.33
   • Paper Nourishing Hope: Five Essential Nutrition Tips for Patients With Pancreatic Cancer. DOI 10.6004/jadpro.2026.17.2.2↗
4. Eric Scott Christenson · 1 shared paper, 2026 · strength 0.20
   • Paper The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced p… DOI 10.1038/s41467-026-69294-3↗
5. Robert A. Anders · 1 shared paper, 2026 · strength 0.20
   • Paper The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced p… DOI 10.1038/s41467-026-69294-3↗
6. Dung Thi Le · 1 shared paper, 2026 · strength 0.20
   • Paper The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced p… DOI 10.1038/s41467-026-69294-3↗
7. Ding Ding · 1 shared paper, 2026 · strength 0.20
   • Paper The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced p… DOI 10.1038/s41467-026-69294-3↗
8. Hao Wang · 1 shared paper, 2026 · strength 0.20
   • Paper The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced p… DOI 10.1038/s41467-026-69294-3↗
9. Kelly J. Lafaro · 1 shared paper, 2026 · strength 0.20
   • Paper The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced p… DOI 10.1038/s41467-026-69294-3↗
10. Valerie Lee · 1 shared paper, 2026 · strength 0.20
    • Paper The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced p… DOI 10.1038/s41467-026-69294-3↗
11. Richard Andrew Burkhart · 1 shared paper, 2026 · strength 0.20
    • Paper The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced p… DOI 10.1038/s41467-026-69294-3↗
12. Elizabeth M. Jaffee · 1 shared paper, 2026 · strength 0.20
    • Paper The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced p… DOI 10.1038/s41467-026-69294-3↗
13. Lei Zheng · 1 shared paper, 2026 · strength 0.20
    • Paper The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced p… DOI 10.1038/s41467-026-69294-3↗
14. Arsen Osipov · 1 shared paper, 2026 · strength 0.20
    • Paper The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced p… DOI 10.1038/s41467-026-69294-3↗
15. Michael Jon Pishvaian · 1 shared paper, 2026 · strength 0.20
    • Paper The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced p… DOI 10.1038/s41467-026-69294-3↗
16. Daniel A. Laheru · 1 shared paper, 2026 · strength 0.20
    • Paper The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced p… DOI 10.1038/s41467-026-69294-3↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.